FUTURAGENE LIMITED

Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  +546.8%

  £164,461 → £1,063,766

• Net assets

  +4,074.2%

  £23,174 → £967,332

• Employees

  —

  Not reported

• Operating profit

  -66.8%

  -£6,614,338 → -£11,034,612

• Profit before tax

  -66.5%

  -£6,614,338 → -£11,015,923

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. FUTURAGENE LIMITED 2010-07-21 → present
2. FUTURAGENE PLC 2004-06-14 → 2010-07-21
3. OVERNET DATA PLC 2000-07-18 → 2004-06-14
4. OVERNET DATA (HOLDINGS) LIMITED 2000-05-19 → 2000-07-18

Accounting basis

IFRS

Reporting scope

Standalone (parent only)

Auditor

S&W Partners Audit Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Company made a loss for the year of $14.7m and had net current assets of $1.294m. The Directors have prepared forecasts for at least twelve months from the date of approval of the financial statements. The forecasts show that the Company is reliant on the financial support of the Ultimate Holding Company, Suzano S.A. Agreed budgeted further funding from the Ultimate Holding Company, during 2026... The Company, therefore, continues to adopt the going concern basis in preparing its individual financial statements.”

Group structure

1. FUTURAGENE LIMITED · parent
   1. FuturaGene Inc. 100% · USA · acquisition, development and commercialisation of intellectual property licensed from a number of universities and research institutes in the field of agricultural biotechnology
   2. FuturaGene Delaware Inc. 100% · USA · acquisition, development and commercialisation of intellectual property licensed from a number of universities and research institutes in the field of agricultural biotechnology
   3. FuturaGene Israel Limited 100% · Israel · acquisition, development and commercialisation of intellectual property licensed from a number of universities and research institutes in the field of agricultural biotechnology

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

12

last 12 months

Capital events

6

last 24 months

Officers appointed

3

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.